Amantadine: Difference between revisions
From Pharmacopedia
More actions
| [unchecked revision] | [pending revision] |
MDElliottMD (talk | contribs) Auto-created stub |
Sentence-case category link per house style (NMDA_Receptor_Antagonists → NMDA_receptor_antagonists) |
||
| (7 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{MedTemplate | {{MedTemplate | ||
| generic | | generic = Amantadine | ||
| brand | | brand = Symmetrel | ||
| classes | | structure = | ||
| mechanism | | classes = Antiparkinsonian | ||
| mechanism = NMDA antagonist; dopamine releasing agent | |||
| uses = | |||
| starting_dose = | |||
| preparations = | |||
| fda_max = | |||
| routes = | |||
| onset = | |||
| duration = | |||
| halflife = | |||
| bioavailability = | |||
| pregnancy = | |||
| legal = | |||
| intro = | |||
| pharmacokinetics = | |||
| pharmacodynamics = | |||
| indications = | |||
| dosing = | |||
| effects = | |||
| interactions = <pharmaInteractions/> | |||
| pregnancy_details = | |||
| monitoring = | |||
| counseling = | |||
| anecdotes = | |||
| seealso = | |||
| references = | |||
}} | }} | ||
[[Category:Antiparkinsonism agents]] | |||
[[Category:Antiparkinsonian]] | [[Category:Antiparkinsonian]] | ||
[[Category:Adamantanes]] | |||
[[Category:NMDA receptor antagonists]] | |||